Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Neoadjuvant Treatment MRI Based AI System to Predict Pathologic Complete Response for Patients With Rectal Cancer: A Multicenter, Prospective Clinical Study

NCT04278274 is registered in ClinicalTrials.gov with Sixth Affiliated Hospital, Sun Yat-sen University as lead sponsor.

NCT NCT04278274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04278274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Neoadjuvant Treatment MRI Based AI System to Predict Pathologic Complete Response for Patients With Rectal Cancer: A Multicenter, Prospective Clinical Study
Lead sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Phase
Observational
Overall status
Unknown status
Start date
February 8, 2020
Completion date
March 31, 2023
Enrollment
205 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer